Short answer: Your triglyceride-to-HDL ratio is one number you can calculate from a standard lipid panel — divide your triglycerides by your HDL cholesterol. It matters because it tends to rise early, when insulin resistance is brewing, often years before fasting glucose or an HbA1c looks abnormal. In US units (mg/dL), a ratio under about 2 is reassuring, and a ratio above roughly 3 to 3.5 is a flag worth paying attention to. It is a useful, cheap signal — not a diagnosis — and it is far less reliable in some groups than others. Here is what the evidence actually supports, where it breaks down, and what to do with the number.
What the ratio is, and why anyone looks at it
Every routine cholesterol panel reports triglycerides and HDL (“good”) cholesterol. The triglyceride-to-HDL ratio (TG/HDL) is just the first divided by the second. If your triglycerides are 150 mg/dL and your HDL is 50 mg/dL, your ratio is 3.0.
The reason this simple division carries information is that the two numbers tend to move together in a revealing way. When the body becomes resistant to insulin — the early, often silent stage on the road to type 2 diabetes — triglycerides typically drift up and HDL drifts down. So a single ratio captures both halves of that shift at once, which is why a 2024 review in Biomedicines described the TG/HDL ratio as a practical surrogate marker for insulin resistance. It does not require a special test, an extra blood draw, or a referral — it is sitting in lab work most adults already have.
That is the appeal: insulin resistance is common, it is treatable, and it is largely invisible in its early years. A number you already have that nudges toward it earlier than glucose does is worth understanding.
What it’s actually measuring
It helps to separate what the ratio reflects from what it predicts.
The cleanest validation comes from work at Stanford by Tracey McLaughlin, Gerald Reaven, and colleagues. In a 2003 study in the Annals of Internal Medicine, they directly measured insulin action in 258 non-diabetic, overweight adults using rigorous lab techniques, then asked which cheap markers best identified the insulin-resistant individuals. A TG/HDL ratio of about 3.0 (in mg/dL units) performed about as well as more complicated calculations for flagging insulin resistance. That is the population the threshold was built in — overweight, non-diabetic adults — and it is worth holding onto, because thresholds do not automatically transfer to everyone.
There is also a structural reason the ratio tracks cardiovascular risk and not just blood sugar. LDL (“bad”) cholesterol comes in different particle sizes, and small, dense LDL particles are considered more atherogenic — more likely to lodge in artery walls — than large, buoyant ones. A 2004 study in the American Journal of Cardiology by Hanak and colleagues measured LDL particle type directly in 658 people and found that a TG/HDL ratio of 3.8 split the groups cleanly: about 79% of those above it had the small-dense (pattern B) profile, and about 81% of those below it had the larger, less harmful (pattern A) profile. So a high ratio is not only a hint about insulin — it is a reasonable stand-in for an unfavorable LDL particle pattern that a basic panel cannot otherwise see.
What the evidence says about heart risk
The most-cited evidence linking the ratio to actual heart attacks comes from a 1997 study in Circulation led by J. Michael Gaziano at Harvard. Comparing 340 people who had a heart attack with 340 matched controls, the researchers found that people in the highest quarter of TG/HDL ratio had about 16 times the risk of a heart attack compared with those in the lowest quarter (relative risk 16.0; 95% confidence interval 7.7 to 33.1).
That number is genuinely striking, and it deserves two pieces of context so it is not over-read. First, it is a relative risk comparing the extreme ends of the distribution — the top quarter against the bottom quarter — not the risk faced by someone with a merely middling ratio. Second, it is a case-control study, which is good at detecting associations but cannot by itself prove the ratio causes events; the ratio may partly be a flag for the cluster of problems that travel with insulin resistance. Larger, longer studies since then have continued to find that a higher ratio predicts more cardiovascular disease and more type 2 diabetes, which is consistent with the early signal idea — but “predicts” is the right verb, not “causes.”
The practical upshot holds: as an early, low-cost flag, the ratio earns its place. As a precise risk calculator for one individual, it does not — that is what validated tools and a clinician are for.
How to read your own number — and the units trap
This is the part most people get wrong, and it can flip the interpretation entirely.
The thresholds above — roughly 2, 3, 3.8 — are all in US units, mg/dL. Much of the world, including the UK, Canada, Australia, and most of Europe, reports lipids in mmol/L. Triglycerides and HDL convert between the two systems using different factors (triglycerides are divided by about 88.5 to get mmol/L; HDL by about 38.7). Because the two factors differ, the ratio itself changes value depending on the units — they are not interchangeable.
In rough terms, a mg/dL ratio is about 2.3 times the mmol/L ratio. So a “concerning” mg/dL ratio of 3.5 corresponds to roughly 1.5 in mmol/L, and an “ideal” mg/dL ratio under 2 is roughly under 0.9 in mmol/L. If you plug mmol/L numbers into a mg/dL threshold, almost everyone looks perfect — which is exactly the kind of false reassurance worth avoiding. Before you do anything with your ratio, check which units your lab report uses, and compare against thresholds in those same units.
A few other practicalities:
- It should be a fasting sample. Triglycerides rise after eating, so a non-fasting draw can inflate the ratio. The thresholds here come from fasting studies.
- It is not a single-reading verdict. Triglycerides bounce around with recent meals, alcohol, and illness. A trend across a couple of fasting panels is far more meaningful than one number.
Where the evidence is weak — this matters
The biggest limitation is not subtle, and it is the reason this ratio should never be applied blindly: it does not work the same way across racial and ethnic groups.
In particular, the ratio is a poor marker of insulin resistance in people of African descent. Researchers describe a “triglyceride paradox”: Black adults often have lower triglycerides even when they are insulin resistant, so the ratio stays falsely low and misses the problem. A study comparing overweight White, African American, South African, and West African women found the TG/HDL ratio predicted insulin resistance reasonably well in White women but fell below a useful threshold in all three groups of Black women. Earlier work in JAMA Internal Medicine reached the same conclusion — that fasting triglycerides and the TG/HDL ratio are not reliable markers of insulin resistance in African Americans. For these populations, blood pressure and glucose-based measures carry more signal, and a normal ratio should not be taken as the all-clear.
A few more honest caveats:
- A normal ratio is not a guarantee. Plenty of cardiovascular risk — high LDL, high blood pressure, smoking, family history — is invisible to this one number. A reassuring ratio does not cancel those out.
- It is a screening flag, not a target to game. The ratio is interesting because of what drives it. Trying to manipulate the number itself — rather than addressing the insulin resistance or diet pattern underneath — misses the point.
- Thresholds are approximate. The 2, 3, and 3.8 figures are useful guides drawn from specific study populations, not bright lines where risk suddenly switches on.
What actually moves it
If your fasting ratio is elevated and you are in a group where it is informative, the encouraging part is that the same changes that lower it are the ones that improve insulin sensitivity and heart health broadly — there is no separate “ratio diet.”
- Move regularly. Aerobic activity and not sitting for long stretches both improve insulin sensitivity, which is the lever underneath the ratio. This is the highest-confidence change in the whole picture.
- Cut back on refined carbohydrate, added sugar, and alcohol. Triglycerides — the numerator — are especially responsive to these. Reducing them tends to move the ratio more quickly than most other changes.
- Lose excess weight if it applies to you. Even modest weight loss improves insulin sensitivity and the lipid pattern that feeds the ratio.
- Treat it as a conversation starter with a clinician, not a self-diagnosis. An elevated ratio is a reasonable prompt to look more carefully — fasting glucose, HbA1c, a full lipid profile, blood pressure — not a reason for alarm on its own.
The bottom line
The triglyceride-to-HDL ratio is one of the most accessible early signals of metabolic trouble: a number you can pull from an ordinary lipid panel that tends to rise while insulin resistance is still silent. In US units, under 2 is reassuring and above roughly 3 to 3.5 is worth attention — but only if you check your units, use a fasting sample, look at the trend rather than one reading, and remember that it is unreliable in people of African descent. Read that way, it is a genuinely useful flag. Read carelessly, it is false reassurance. Use it to ask better questions, not to answer them on your own.
References
- Baneu P, Văcărescu C, Drăgan SR, et al. The Triglyceride/HDL Ratio as a Surrogate Biomarker for Insulin Resistance. Biomedicines, 2024;12(7):1493. mdpi.com
- McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistant. Annals of Internal Medicine, 2003;139(10):802–809. acpjournals.org
- Hanak V, Munoz J, Teague J, Stanley A, Bittner V. Accuracy of the triglyceride to high-density lipoprotein cholesterol ratio for prediction of the low-density lipoprotein phenotype B. American Journal of Cardiology, 2004;94(2):219–222. pubmed.ncbi.nlm.nih.gov
- Gaziano JM, Hennekens CH, O’Donnell CJ, Breslow JL, Buring JE. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation, 1997;96(8):2520–2525. pubmed.ncbi.nlm.nih.gov
- Sumner AE, Finley KB, Genovese DJ, Criqui MH, Boston RC. Fasting triglyceride and the triglyceride–HDL cholesterol ratio are not markers of insulin resistance in African Americans. JAMA Internal Medicine (Archives of Internal Medicine), 2005. jamanetwork.com
- Yu SSK, Castillo DC, Courville AB, Sumner AE. The triglyceride paradox in people of African descent. Metabolic Syndrome and Related Disorders, 2012;10(2):77–82. pmc.ncbi.nlm.nih.gov
- Knight MG, Goedecke JH, Ricks M, et al. The TG/HDL-C ratio does not predict insulin resistance in overweight women of African descent. Ethnicity & Disease, 2011;21(4):490–494. pubmed.ncbi.nlm.nih.gov